MedPath
NMPA Approval

Cetrorelix Acetate Powder for Injection

国药准字HJ20140476

March 1, 2024

H20140476

Drug Information

注射用醋酸西曲瑞克

思则凯

注射剂

0.25mg(以西曲瑞克计)

化学药品

March 1, 2024

February 28, 2029

Company Information

Applicant Company

Merck (Schweiz) AG

Chamerstrasse 174, 6300 Zug, Switzerland

Manufacturing Company

FAREVA PAU

FAREVA PAU 1, Avenue du Béarn, 64320 IDRON, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用醋酸西曲瑞克 - NMPA 批准文号 | MedPath